Matches in Wikidata for { <http://www.wikidata.org/entity/Q93206790> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q93206790 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93206790 description "scientific article published on 24 April 2020" @default.
- Q93206790 description "wetenschappelijk artikel" @default.
- Q93206790 description "наукова стаття, опублікована 24 квітня 2020" @default.
- Q93206790 name "Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study" @default.
- Q93206790 name "Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study" @default.
- Q93206790 type Item @default.
- Q93206790 label "Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study" @default.
- Q93206790 label "Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study" @default.
- Q93206790 prefLabel "Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study" @default.
- Q93206790 prefLabel "Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study" @default.
- Q93206790 P1433 Q93206790-6AC30B55-0AA5-4A1E-BB43-E02C8FC9BBCC @default.
- Q93206790 P1476 Q93206790-C80A8111-9BC5-4BA9-977A-B1DB40B43712 @default.
- Q93206790 P2093 Q93206790-147BA2C9-9D60-42E9-9F5E-FA88847CBA52 @default.
- Q93206790 P2093 Q93206790-1B8CFA56-C8FC-4A80-A5FF-3C6EB7748A48 @default.
- Q93206790 P2093 Q93206790-1EEEDDEF-A2D7-41DC-BFA4-D52D93B53451 @default.
- Q93206790 P2093 Q93206790-49EFBA64-3C74-425A-927B-7A317FCC4A2C @default.
- Q93206790 P2093 Q93206790-56F5169E-E3DF-4AA7-AE58-8A9D561E9CC3 @default.
- Q93206790 P2093 Q93206790-5AEA23D0-98FB-4C7F-A935-85C2185179B3 @default.
- Q93206790 P2093 Q93206790-90535F93-86E2-4989-89C6-ED441B399F08 @default.
- Q93206790 P2093 Q93206790-9E1664A2-3901-4F84-A0C5-BF6E8A9E1975 @default.
- Q93206790 P2093 Q93206790-BBD31D0B-B3CD-4D7F-AA9E-B2FC57C3C7A5 @default.
- Q93206790 P2093 Q93206790-C71AF01B-046E-4A2C-BC08-1E00292BB129 @default.
- Q93206790 P2093 Q93206790-FC4FE07B-3E54-4035-BC77-544218F5D6F1 @default.
- Q93206790 P304 Q93206790-53464689-CC1E-439B-98FC-D92A180876CA @default.
- Q93206790 P31 Q93206790-C172EB2B-A4E3-46DF-9308-4CE127A69277 @default.
- Q93206790 P356 Q93206790-FF1E4F1A-9E8E-46B1-A349-3BDD23C559FE @default.
- Q93206790 P50 Q93206790-0D0696D9-134D-437E-8059-EC7ABE4DE389 @default.
- Q93206790 P50 Q93206790-141981D2-A69E-45EB-AA76-2F5A071090E9 @default.
- Q93206790 P50 Q93206790-1B8FBFB4-C420-4E33-8219-4228EAAA60AC @default.
- Q93206790 P50 Q93206790-6CA61A63-90AF-4D64-A122-528E7F2FD4A7 @default.
- Q93206790 P50 Q93206790-892A673F-A7E6-45EC-B03E-63D91C0E0E6D @default.
- Q93206790 P50 Q93206790-9A19B19C-65DA-443E-82DB-F7E8FA5077FB @default.
- Q93206790 P50 Q93206790-A05B805C-4315-481D-A159-DC73A83BB4E5 @default.
- Q93206790 P50 Q93206790-E216882A-8CD2-4FFF-994D-07B21E658BA8 @default.
- Q93206790 P50 Q93206790-E4ED33F3-A3E1-4E45-BAF4-9C7E92F26931 @default.
- Q93206790 P50 Q93206790-FBF3EFA8-ECAC-4444-868C-F6707C507B9A @default.
- Q93206790 P577 Q93206790-A2027052-98C6-4827-AD09-B93FB2AB4928 @default.
- Q93206790 P698 Q93206790-8396A90F-F63E-4088-B5C8-F625A8B2974A @default.
- Q93206790 P921 Q93206790-2ABEC18C-C66D-4E16-A888-9EC668806F81 @default.
- Q93206790 P932 Q93206790-04413C81-7423-4581-A9E5-A0E7EDE0C12F @default.
- Q93206790 P356 JCO.19.02484 @default.
- Q93206790 P698 32330102 @default.
- Q93206790 P1433 Q400292 @default.
- Q93206790 P1476 "Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study" @default.
- Q93206790 P2093 "Antonio Di Meglio" @default.
- Q93206790 P2093 "Caroline Block" @default.
- Q93206790 P2093 "Frederick Briccetti" @default.
- Q93206790 P2093 "Jiani Hu" @default.
- Q93206790 P2093 "Kelly O'Neil" @default.
- Q93206790 P2093 "Lindsey Milisits" @default.
- Q93206790 P2093 "Meredith Faggen" @default.
- Q93206790 P2093 "Michael Constantine" @default.
- Q93206790 P2093 "Michael Hassett" @default.
- Q93206790 P2093 "Natalie Sinclair" @default.
- Q93206790 P2093 "Rebecca Rees" @default.
- Q93206790 P304 "JCO1902484" @default.
- Q93206790 P31 Q13442814 @default.
- Q93206790 P356 "10.1200/JCO.19.02484" @default.
- Q93206790 P50 Q109562169 @default.
- Q93206790 P50 Q125263731 @default.
- Q93206790 P50 Q16887072 @default.
- Q93206790 P50 Q62743897 @default.
- Q93206790 P50 Q87608362 @default.
- Q93206790 P50 Q89253229 @default.
- Q93206790 P50 Q89531596 @default.
- Q93206790 P50 Q90198507 @default.
- Q93206790 P50 Q90371024 @default.
- Q93206790 P50 Q91305067 @default.
- Q93206790 P577 "2020-04-24T00:00:00Z" @default.
- Q93206790 P698 "32330102" @default.
- Q93206790 P921 Q423762 @default.
- Q93206790 P932 "7367545" @default.